Congress scientific chair Cristina Avendaño discussing the EACPT Madrid conference

Cristina Avendaño

Around 800 delegates are now in Madrid for the  12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics which is being held from 27th to 30th June 2015. 

Over 500 abstracts have been accepted from 66 countries from all 5 continents for presentation as e-posters and oral presentations.

In this recording at the start of the Congress, Cristina Avendaño, Chair of the Congress Scientific Committee and Chair of the Spanish Society for Clinical Pharmacology  discusses her hopes for this important international event with EACPT Secretary Donald Singer.

EMA health professional working party elects EACPT's Gonzalo Calvo as its first co-chair

Gonzalo Calvo, chair of the European Association for Clinical Pharmacology and Therapeutics (EACPT), is the new co-chair of the HCPWP of the European Medicines Agency. 

Professor Calvo is a consultant in clinical pharmacology in Barcelona and has extensive experience both in medicines regulation, including nearly ten years as member of the Agency’s Committee for Medicinal Products for Human Use (CHMP), and in learned societies. This is the first time that the HCPWP has elected a co-chair, following its formal establishment in June 2013.  

The Patients' and Consumers' Working Party (PCWP) and the Healthcare Professionals' Working Party (HCPWP) of the European Medicines Agency (EMA) both elected their new co-chairs on 26th September, 2013.

David Haerry of the European AIDS TreatmentGroup (EATG) is the new co-chair of the PCWP. He has 15 years experience as an advocate for HIV patients’ rights and has been a member of the PCWP since 2006. He will replace Lise Murphy of the European Organisation for Rare Diseases (EURORDIS), who was co-chair of the PCWP since 2010 and whose mandate has come to an end. The PCWP was established in 2005.

Both David Haerry and Gonzalo Calvo will co-chair these working parties for the next three years, together with Isabelle Moulon, Head of Patients and Healthcare Professionals at the EMA.

The main role of the PCWP and the HCPWP is to provide recommendations to the EMA and its scientific committees on all matters of interest to either patients and consumers or healthcare professionals in relation to medicinal products, as well as to monitor interactions between the Agency and patients, consumers and healthcare professionals.

EACPT Executive Committee members Professor Donald Singer from the UK and Professor Ingolf Cascorbi from Germany are also members of the EMA Health Care Professionals Working Party.

Professor Simon Maxwell, co-chair of the EACPT Educational Subcommittee, is observer on behalf of the HCP-WP on the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCPeP).

Update on 4-6 July 2013 EACPT Summer School in Edinburgh

2013 EACPT Summer School: final programme

Date: 4 - 6 July 2013

Location: Royal College of Physicians, Edinburgh

The programme includes over 30 speakers. 

Keynote lecturers from around Europe include:

Ingolf Cascorbi, University of Kiel
Adam Cohen, Centre for Human Drug Research, Leiden
Munir Pirmohamed, University of Liverpool
Sir Michael Rawlins, Royal Society of Medicine, former chairman of NICE, London
Sir Kent Woods, MHRA, London 

Local organisers for the 2013 EACPT Summer School  are Professor David Webb and Professor Simon Maxwell.

The Summer School programme consists of keynote presentations on all aspects of clinical pharmacology by invited expert speakers, workshops, poster presentations, free communications and social events. There will be a strong interactive element and the opportunity for delegates to network with the speakers. 

 

See also information on the 11th EACPT Congress in Geneva: 28th - 31st August, 2013

Special Award for services to the EACPT for Michael Orme

The EACPT presented a Special Award for services to the EACPT for Professor Michael Orme. 

The Award was accepted on his behalf at the 11th EACPT Congress in Geneva by EACPT co-founder Professor Folke Sjöqvist. 

Michael Orme  qualified in medicine from Cambridge University and King’s College Hospital in London in 1965. He trained in internal medicine and clinical pharmacology at the Royal Postgraduate Medical School in London and at the Karolinska Institute in Stockholm, Sweden. He was appointed as senior lecturer in clinical pharmacology at Liverpool University Medical School in 1975 and was promoted to a personal chair in 1984. He was Dean of the Faculty of Medicine in Liverpool from 1991- 1996.  

He co-edited the 2012 manifesto from WHO, CIOMS and IUPHAR on Clinical Pharmacology in Health Care, Teaching and Research. 

He worked with European clinical pharmacology colleagues in the late nineteen eighties to develop a European approach through the WHO European office in Copenhagen. This led to a meeting in Verona, Italy in 1993 to found the European Association for Clinical Pharmacology and Therapeutics (EACPT). Michael was the first honorary secretary of EACPT from 1995-1999 and he was re-elected to this post for 1999-2003. He was also chairman of the Education Sub-committee of EACPT from 1997 to 2003.  He was elected chairman of EACPT for the period 2003-2007 and remained on the Executive Committee of EACPT as past chairman until 2011. 

In these roles Michael Orme brought his interests in European and global efforts of clinical pharmacology as a medical speciality devoted to the rational use of drugs, to growing EACPT into a major international organisation representing all clinical pharmacology societies in Europe.  

The Special Award was presented at the 11th EACPT Congress in Geneva 28th - 31st August 2013. 

The EACPT was founded 20 years ago and now includes all national organisations for clinical pharmacology in Europe. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Official EACPT journal: Clinical Therapeutics 

More about the 11th EACPT Congress in Geneva.

More about the EACPT. 

Update on 28-31 August 2013 EACPT Congress in Geneva

-->

The abstract deadline for the next biennial EACPT Congress is only 6 weeks away: 8th April 2013.
See the EACPT Congress blog for summaries on many of the symposia to be held during the Congress: from new therapeutic biomarkers, to new biomarker and treatment targets (cancer, eye disease, predictive pharmacogenetics, inborn errors of metabolism, therapeutic drug monitoring ...), and how to improve safety in prescribing ...

The Congress will be held at the International Congress Centre of Geneva from 28 to 31 August 2013. 

-->
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

Abstract submission

Registration

2013 EACPT Geneva Congress website.

Strategy development for the EACPT

EC members from UK, Sweden, Croatia and Italy

The European Association for Clinical Pharmacology and Therapeutics provides expert advice for European policy makers and medicines agencies, and organises congresses and workshops providing key information on the latest advances in research, education and policy on drug development and on the efficacy and safety of new and established medicines and their management. The EACPT  provides important additional support for its members, including representation and advocacy, training, and other aspects of development of the specialty.

EC members from France, Holland, Denmark, Finland and Germany

The international landscape for learned medical societies is evolving rapidly as a result of several key factors, including the impact of advances in molecular technology on drug discovery and development, changes in populations demographics, emergence of new therapeutic challenges,  the current global economic climate, and the effects of new e-technologies on ways of working and interacting for health and industry professionals, researchers and other interested in clinical sciences.

EC members from Holland, Spain, Germany & Hungary

The EACPT Executive Committee is in the process of conducting one of its regular strategy reviews, including evaluation of opportunities for the Assocation and its communities arising from the above developments. Results and actions arising from the strategy review will be discussed at the next biennial EACPT Congress to be held in Geneva 28-31 August 2013.

More on the EACPT Geneva 2013 Congress.

European Association of Clinical Pharmacology and Therapeutics Summer School 2013, Edinburgh

The 2013 EACPT Summer School will be held in Edinburgh, organised by Professor David Webb and Professor Simon Maxwell.

Date: 4 - 6 July 2013

Location: Royal College of Physicians, Edinburgh

Event flyer

The Summer School programme will consist of keynote presentations on all aspects of clinical pharmacology by invited expert speakers, workshops, poster presentations, free communications and social events. There will be a strong interactive element and the opportunity for delegates to network with the speakers. 

Bursaries will be available. 

For more information and to register your interest, please email meetings@bps.ac.uk

See also information on 11th EACPT Congress, Geneva 28 - 31 August, 2013